"Treatment Failure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.
| Descriptor ID |
D017211
|
| MeSH Number(s) |
E01.789.800.760 N04.761.559.590.800.760 N05.715.360.575.575.800.760
|
| Concept/Terms |
Treatment Failure- Treatment Failure
- Failure, Treatment
- Failures, Treatment
- Treatment Failures
|
Below are MeSH descriptors whose meaning is more general than "Treatment Failure".
Below are MeSH descriptors whose meaning is more specific than "Treatment Failure".
This graph shows the total number of publications written about "Treatment Failure" by people in this website by year, and whether "Treatment Failure" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 4 | 4 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 4 | 4 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 7 | 7 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 6 | 6 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 5 | 5 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 13 | 13 |
| 2008 | 1 | 8 | 9 |
| 2009 | 0 | 10 | 10 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 11 | 11 |
| 2013 | 0 | 7 | 7 |
| 2014 | 0 | 10 | 10 |
| 2015 | 0 | 10 | 10 |
| 2016 | 0 | 9 | 9 |
| 2017 | 0 | 9 | 9 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Failure" by people in Profiles.
-
Central Venous Catheter Salvage in Ambulatory Central Line-Associated Bloodstream Infections. Pediatrics. 2021 12 01; 148(6).
-
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939.
-
Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960.
-
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
-
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 12 10; 383(24):2333-2344.
-
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial. JAMA. 2020 10 20; 324(15):1522-1531.
-
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020 05; 79(5):618-625.
-
Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac?Resynchronization Device Therapy. J Am Coll Cardiol. 2019 11 26; 74(21):2588-2603.
-
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer. 2020 01 15; 126(2):293-303.
-
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy. Gastroenterology. 2019 12; 157(6):1506-1517.e1.